Skip to main content
Premium Trial:

Request an Annual Quote

Orchid Cellmark Extends UK Scrapie Genotyping Contract; Deal Worth More than $7M

NEW YORK (GenomeWeb News) - Orchid Cellmark today said it has renewed an ongoing contract with the United Kingdom to continue offering genotyping services to sheep farmers in an effort to combat scrapie.
The company reported that the contract, awarded under the National Scrapie Plan for Great Britain, is worth more than $3.5 million per year.
The UK government extended the contract through 2007 and 2008, Orchid said.
Orchid will use its DNA testing services to help sheep farmers breed sheep that are less genetically susceptible to the disease. The UK plan hopes to use genetic analysis to completely eradicate the disease.
Scrapie, a spongiform encephalopathy named for one of its symptoms (sheep with scrapie tend to scrape their fleece against rocks and fences), causes significant losses to farmers around the world annually.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.